Sun Pharma gains on export demand and sector stability

Sun Pharma rose 2.92% this week helped by firm export demand and stable pricing in key regulated markets. Healthcare stocks maintained defensive appeal through broad market swings, supporting steady upward movement. Investors tracked product pipeline updates and regulatory developments across geographies. The stock held firm into the weekend.